ProQR Therapeutics N.V.
PRQR
$1.98
$0.031.54%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -22.22% | -8.91% | |||
| Total Other Revenue | -78.47% | -23.24% | |||
| Total Revenue | -24.46% | -9.58% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -24.46% | -9.58% | |||
| SG&A Expenses | -33.29% | 60.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.85% | 12.47% | |||
| Operating Income | 5.10% | -22.14% | |||
| Income Before Tax | 6.77% | -30.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.91% | -30.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.91% | -30.32% | |||
| EBIT | 5.10% | -22.14% | |||
| EBITDA | 5.54% | -23.12% | |||
| EPS Basic | 6.94% | -30.29% | |||
| Normalized Basic EPS | 6.84% | -30.00% | |||
| EPS Diluted | 10.35% | -29.47% | |||
| Normalized Diluted EPS | 6.84% | -30.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.04% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||